Jw Holdings Market Cap ($185.92 Million)
Market Cap & Net Worth: Jw Holdings (096760)
Jw Holdings market cap. Jw Holdings (KO:096760) has a market capitalization of $185.92 Million (₩274.34 Billion) as of November 1, 2026. Listed on the KO stock exchange, this Korea-based company holds position #16617 globally and #613 in its home market, demonstrating a 0.51% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Jw Holdings's stock price ₩3965.00 by its total outstanding shares 69190827 (69.19 Million). Also see cash efficiency ratio of Jw Holdings for how efficiently the company converts equity into cash flow.
Jw Holdings Market Cap History (2015–2026)
Jw Holdings market cap history from 2015 to 2026. Data shows change from $296.82 Million to $185.92 Million (-3.90% CAGR). Check today's stock price for Jw Holdings for real-time trading data and today's change.
Jw Holdings Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Jw Holdings's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Jw Holdings net asset momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.00x
Jw Holdings's market cap is 0.00 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.00x
Jw Holdings's market cap is 0.00 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $296.82 Million | $622.83 Billion | $181.41 Million | 0.00x | 1.64x |
| 2016 | $302.28 Million | $680.48 Billion | -$8.66 Billion | 0.00x | N/A |
| 2017 | $293.46 Million | $683.72 Billion | $54.02 Billion | 0.00x | 0.01x |
| 2018 | $258.58 Million | $725.37 Billion | $23.17 Billion | 0.00x | 0.01x |
| 2019 | $240.33 Million | $726.42 Billion | -$33.44 Billion | 0.00x | N/A |
| 2020 | $230.86 Million | $781.95 Billion | $10.67 Billion | 0.00x | 0.02x |
| 2021 | $143.69 Million | $788.94 Billion | -$2.78 Billion | 0.00x | N/A |
| 2022 | $129.09 Million | $864.54 Billion | $22.15 Billion | 0.00x | 0.01x |
| 2023 | $163.64 Million | $928.07 Billion | $19.03 Billion | 0.00x | 0.01x |
| 2024 | $141.61 Million | $887.71 Billion | $62.62 Billion | 0.00x | 0.00x |
Competitor Companies of 096760 by Market Capitalization
Companies near Jw Holdings in the global market cap rankings as of November 1, 2026. Also see Jw Holdings asset portfolio for a full breakdown of the balance sheet.
Key companies related to Jw Holdings by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #511 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #535 globally with a market cap of $50.42 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #593 globally with a market cap of $45.23 Billion USD ( CN¥309.13 Billion CNY).
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #619 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #511 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #535 | GALDERMA GROUP AG | NYSE:GALDY | $50.42 Billion | $46.62 |
| #593 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $45.23 Billion | CN¥48.46 |
| #619 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €18.30 |
Market Capitalization of Jw Holdings (2015–2026)
Market capitalization of Jw Holdings from 2015 to today. Between 2015 and today, Jw Holdings's market cap moved from $296.82 Million to $ 185.92 Million, with a yearly change of -3.90%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩185.92 Million | +10.45% |
| 2025 | ₩168.33 Million | +18.87% |
| 2024 | ₩141.61 Million | -13.47% |
| 2023 | ₩163.64 Million | +26.77% |
| 2022 | ₩129.09 Million | -10.16% |
| 2021 | ₩143.69 Million | -37.76% |
| 2020 | ₩230.86 Million | -3.94% |
| 2019 | ₩240.33 Million | -7.06% |
| 2018 | ₩258.58 Million | -11.89% |
| 2017 | ₩293.46 Million | -2.92% |
| 2016 | ₩302.28 Million | +1.84% |
| 2015 | ₩296.82 Million | -- |
End of Day Market Cap According to Different Sources
On Oct 31st, 2026 the market cap of Jw Holdings was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $185.92 Million USD |
| MoneyControl | $185.92 Million USD |
| MarketWatch | $185.92 Million USD |
| marketcap.company | $185.92 Million USD |
| Reuters | $185.92 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Jw Holdings
JW Holdings Corporation, together with its subsidiaries, operates as a healthcare company in South Korea, the United States, Japan, China, and internationally. The company offers amino acid solutions, gastrointestinal agents, wound care, eye care, liver disease treatment, cold medicine, API, oral and topical analgesic, and other miscellaneous pharmaceutical products. It also offers hairdye, hair … Read more